Moloney Securities Asset Management, LLC Windtree Therapeutics Inc Transaction History

Moloney Securities Asset Management, LLC

  • $714 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 27, 2021
SELL
$1.66 - $2.27 $18,077 - $24,720
-10,890 Closed
0 $0
Q2 2021

Jul 26, 2021
BUY
$1.68 - $2.79 $18,295 - $30,383
10,890 New
10,890 $25,000

Others Institutions Holding WINT

# of Institutions
2
Shares Held
4.09K
Call Options Held
0
Put Options Held
0
View Full List

About WINDTREE THERAPEUTICS INC

WINT Quotes by TradingView
  • Ticker WINT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,627,900
  • Market Cap $9.8M
  • Description
  • Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...
More about WINT
Track This Portfolio

Track Moloney Securities Asset Management, LLC Portfolio

Follow Moloney Securities Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email